U.S. District Court for the District of Columbia (Holtzoff, 1957-10-11: Hoxsey's suit to enjoin the FDA's public warning was dismissed: the court held that 21 U.S.C. 375(b) authorises dissemination of information about imminent danger or gross deception and does not require a prior adjudicative hearing.
The Food and Drug Administration has issued a circular, copies of which are being posted in post offices throughout the country, warning the public that the so-called Hoxsey cancer treatment has been found worthless insofar as internal cancer is concerned.
p. 377
U.S. District Court for the District of Columbia (Holtzoff, 1957-10-11: Hoxsey's suit to enjoin the FDA's public warning was dismissed: the court held that 21 U.S.C. 375(b) authorises dissemination of information about imminent danger or gross deception and does not require a prior adjudicative hearing. Court record; no funder or conflicts. Directly relevant to the book's 'no fair hearing' framing in a second case: the court held no hearing was required because the FDA made no order adjudicating rights – the agency was warning the public, not licensing or banning a product. Alternate host: courtlistener.com/opinion/2300750 (text loads only in part). Justia text retrieved is a truncated rendering of the opinion.
